Mihael Hristos Polymeropoulos, President and CEO at Vanda Pharmaceuticals Inc. (VNDA), sold 312,470 shares at $8.17 ($2.6M) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Seasonal sale ($2.6M) by President and CEO — this insider has traded VNDA in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.17 | 156,235 | $1.3M | 50.0% |
| 2 | $8.17 | 156,235 | $1.3M | 50.0% |
| Total | $8.17 avg | 312,470 | $2.6M | 100% |
| Filing → |
| VNDA | BUY | 2025-05-19 | $84K | — | Filing → |
| VNDA | BUY | 2025-03-06 | $50K | — | Filing → |
| VNDA | BUY | 2025-03-05 | $50K | — | Filing → |